AHA 2009 schedule: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(28 intermediate revisions by the same user not shown)
Line 1: Line 1:
Here is the page we will use to coordinate interviews at AHA 2009
Here is the page we will use to coordinate interviews at AHA 2009


'''Filming location:''' Phone: 407-
'''Filming location:''' Hilton Orlando 6001 Destination Parkway Orlando, FL 32819
   
   
Filming will occur from Saturday to Tuesday (November 14 - November 17).  Dr. Gibson is available to interview during all times listed '''in black'''.  For all times listed '''<font color="green"> in green</font>''', Dr. Gibson is unavailable to conduct the interview.  You may, however, go ahead and speak about your topic/present your slides.
Filming will occur from Saturday to Tuesday (November 14 - November 17).  Dr. Gibson is available to interview during all times listed '''in black'''.  For all times listed '''<font color="green"> in green</font>''', Dr. Gibson is unavailable to conduct the interview.  You may, however, go ahead and speak about your topic/present your slides.
Line 25: Line 25:


===9:00 AM===
===9:00 AM===
*'''Interviewee:''' Rino Sardella
*'''Interviewee:''' Gennaro Sardella
*'''Trial:''' Impact of Thrombectomy with EXPort Catheter in Infarct Related Artery during Primary PCI on Procedural Outcome in Patients with AMI (EXPIRA Trial). 24 Months Clinical Outcome
*'''Trial:''' Impact of Thrombectomy with EXPort Catheter in Infarct Related Artery during Primary PCI on Procedural Outcome in Patients with AMI (EXPIRA Trial). 24 Months Clinical Outcome


Line 31: Line 31:


===10:00 AM===
===10:00 AM===
*'''Interviewee:''' Philippe Gabriel Steg
*'''Trial:''' PLATO Trial


===10:30 AM===
===10:30 AM===
*'''Interviewee:''' Jeanne E. Poole
*'''Trial:''' Complications Associated with Planned Pacemaker or Defibrillator Lead Addition at the Time of Generator Change: Results from the REPLACE Registry


===11:00 AM===
===11:00 AM===
Line 38: Line 42:
===11:30 AM===
===11:30 AM===


===12:00 PM===
=== <font color="green">12:00 PM</font>===


===12:30 PM===
=== <font color="green">12:30 PM</font>===


===1:00 PM===
=== <font color="green">1:00 PM</font>===


===1:30 PM===
=== <font color="green">1:30 PM</font>===


===2:00 PM===
===2:00 PM===
Line 63: Line 67:
==Sunday November 15, 2009==
==Sunday November 15, 2009==


===8:30 AM===
=== <font color="green">8:30 AM</font>===


===9:00 AM===
=== <font color="green">9:00 AM</font>===


===9:30 AM===
=== <font color="green">9:30 AM</font>===


===10:00 AM===
=== <font color="green">10:00 AM</font>===


===10:30 AM===
=== <font color="green">10:30 AM</font>===


===11:00 AM===
=== <font color="green">11:00 AM</font>===


===11:30 AM===
=== <font color="green">11:30 AM</font>===


===12:00 PM===
=== <font color="green">12:00 PM</font>===


===12:30 PM===
=== <font color="green">12:30 PM</font>===


===1:00 PM===
===1:00 PM===


===1:30 PM===
===1:30 PM===
*'''Interviewee:''' Maria Brooks
*'''Trial:''' Quality of Life Results in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial


===2:00 PM===
===2:00 PM===
*'''Interviewee:''' Bernard Chaitman
*'''Trial:''' Prompt Coronary Revascularization Reduces Non-Fatal Myocardial Infarction in Patients with Type II Diabetes and More Extensive Vascular Disease: Results from BARI2D


=== <font color="green">2:30 PM</font>===
=== <font color="green">2:30 PM</font>===
Line 93: Line 101:
=== <font color="green">3:30 PM</font>===
=== <font color="green">3:30 PM</font>===


===4:00 PM===
=== <font color="green">4:00 PM</font>===
 
 
=== <font color="green">4:30 PM</font>===


===4:30 PM===
*'''Interviewee:''' Philippe Meurin
*'''Trial:''' Non-Steroidal Anti-Inflammatory Treatment for Post-operative Pericardial Effusion: The POPE Study, A Multicenter, Double-blind, Randomized Trial




Line 110: Line 118:
=== <font color="green">9:30 AM</font>===
=== <font color="green">9:30 AM</font>===


=== <font color="green">10:00 AM</font>===
===10:00 AM===
 
*'''Interviewee:''' Christian Hamm
*'''Trial:''' PEPCAD III: A Randomized Trial Comparing a Paclitaxel-Coated Balloon/Stent System with a Sirolimus Eluting Stent 
 
===10:30 AM===
===10:30 AM===
*'''Interviewee:''' Cheuk-Man Yu
*'''Interviewee:''' Cheuk-Man Yu
Line 121: Line 131:


===11:30 AM===
===11:30 AM===
*'''Interviewee:''' Stefan Anker
*'''Trial:''' Ferric Carboxymaltose Assessment in Patients with Iron Deficiency and Chronic Heart Failure With and Without Anemia (FAIR-HF): A Randomized, Double-blind, Placebo-controlled, International Multi-center Phase III Study


===12:00 PM===
===12:00 PM===
*'''Interviewee:''' Philippe Meurin
*'''Trial:''' Non-Steroidal Anti-Inflammatory Treatment for Post-operative Pericardial Effusion: The POPE Study, A Multicenter, Double-blind, Randomized Trial


=== <font color="green">12:30 PM</font>===
=== <font color="green">12:30 PM</font>===
Line 128: Line 142:
=== <font color="green">1:00 PM</font>===
=== <font color="green">1:00 PM</font>===


===1:30 PM===
=== <font color="green">1:30 PM</font>===


===2:00 PM===
=== <font color="green">2:00 PM</font>===


===2:30 PM===
=== <font color="green">2:30 PM</font>===


=== <font color="green">3:00 PM</font>===
=== <font color="green">3:00 PM</font>===
Line 149: Line 163:
===8:30 AM===
===8:30 AM===


===9:00 AM===
=== <font color="green">9:00 AM</font>===


=== <font color="green">9:30 AM</font>===
=== <font color="green">9:30 AM</font>===
Line 158: Line 172:


===10:45 AM===
===10:45 AM===
*'''Interviewee:''' Deepak Bhatt
*'''Trial:''' CHAMPION PLATFORM Trial


===11:00 AM===
===11:15 AM===
*'''Interviewee:''' Robert Harrington
*'''Trial:''' CHAMPION PCI Trial


===11:30 AM===
===11:45 AM===
*'''Interviewee:''' John Camm
*'''Trial:''' Differences in Clinical Outcomes with Rhythm-and Rate-control Therapies for Atrial Fibrillation in the RecordAF Registry


===12:00 PM===
===12:00 PM===
Line 182: Line 202:


===4:30 PM===
===4:30 PM===
*'''Interviewee:''' Marvin Konstam
*'''Trial:''' Comparison of Low-Dose Versus High-Dose Losartan Treatment on Morbidity and Mortality in Angiotensin Converting Enzyme Inhibitor-Intolerant Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction: Results of the HEAAL Study




''[[AHA 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''
''[[AHA 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''

Latest revision as of 19:24, 10 November 2009

Here is the page we will use to coordinate interviews at AHA 2009

Filming location: Hilton Orlando 6001 Destination Parkway Orlando, FL 32819

Filming will occur from Saturday to Tuesday (November 14 - November 17). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides.



Click on Date for Detailed Schedule

Saturday November 14, 2009

Sunday November 15, 2009

Monday November 16, 2009

Tuesday November 17, 2009


Saturday, November 14, 2009

8:30 AM

9:00 AM

  • Interviewee: Gennaro Sardella
  • Trial: Impact of Thrombectomy with EXPort Catheter in Infarct Related Artery during Primary PCI on Procedural Outcome in Patients with AMI (EXPIRA Trial). 24 Months Clinical Outcome

9:30 AM

10:00 AM

  • Interviewee: Philippe Gabriel Steg
  • Trial: PLATO Trial

10:30 AM

  • Interviewee: Jeanne E. Poole
  • Trial: Complications Associated with Planned Pacemaker or Defibrillator Lead Addition at the Time of Generator Change: Results from the REPLACE Registry

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

Return to top

Sunday November 15, 2009

8:30 AM

9:00 AM

9:30 AM

10:00 AM

10:30 AM

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

  • Interviewee: Maria Brooks
  • Trial: Quality of Life Results in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

2:00 PM

  • Interviewee: Bernard Chaitman
  • Trial: Prompt Coronary Revascularization Reduces Non-Fatal Myocardial Infarction in Patients with Type II Diabetes and More Extensive Vascular Disease: Results from BARI2D

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

Return to top

Monday November 16, 2009

8:30 AM

9:00 AM

9:30 AM

10:00 AM

  • Interviewee: Christian Hamm
  • Trial: PEPCAD III: A Randomized Trial Comparing a Paclitaxel-Coated Balloon/Stent System with a Sirolimus Eluting Stent

10:30 AM

  • Interviewee: Cheuk-Man Yu
  • Trial: Results of the Pacing to Avoid Cardiac Enlargement (PACE) Trial

11:00 AM

  • Interviewee: Bruce Rollman
  • Trial: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression: 8-Month Outcomes from The Bypassing The Blues Trial

11:30 AM

  • Interviewee: Stefan Anker
  • Trial: Ferric Carboxymaltose Assessment in Patients with Iron Deficiency and Chronic Heart Failure With and Without Anemia (FAIR-HF): A Randomized, Double-blind, Placebo-controlled, International Multi-center Phase III Study

12:00 PM

  • Interviewee: Philippe Meurin
  • Trial: Non-Steroidal Anti-Inflammatory Treatment for Post-operative Pericardial Effusion: The POPE Study, A Multicenter, Double-blind, Randomized Trial

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

Return to top

Tuesday November 17, 2009

8:30 AM

9:00 AM

9:30 AM

10:00 AM

10:30 AM

10:45 AM

  • Interviewee: Deepak Bhatt
  • Trial: CHAMPION PLATFORM Trial

11:15 AM

  • Interviewee: Robert Harrington
  • Trial: CHAMPION PCI Trial

11:45 AM

  • Interviewee: John Camm
  • Trial: Differences in Clinical Outcomes with Rhythm-and Rate-control Therapies for Atrial Fibrillation in the RecordAF Registry

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

  • Interviewee: Marvin Konstam
  • Trial: Comparison of Low-Dose Versus High-Dose Losartan Treatment on Morbidity and Mortality in Angiotensin Converting Enzyme Inhibitor-Intolerant Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction: Results of the HEAAL Study


Return to top